Expert Review of Anticancer Therapy
Taylor and Francis Ltd.
United Kingdom
journal
SJR by Edition
Subject Categories
- OncologyQ2
- Pharmacology (medical)Q2
Areas: Medicine
Most published research topics
Source: OpenAlex
Publication Statistics
Documents per Year
Detailed Information
ISSN
1473-7140, 1744-8328
SJR Best Quartile
Q2
Region
Western Europe
Citations per Document (2 years)
2.84
References per Document
72.31
Coverage
2001-2026
Scope
Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care. Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.
Metrics from SCImago Journal Rank 2025. View on SCImago